Clinical trials: Haematology
Haematology
Hematological Profiles of Preterm Infants and the Impact of Antenatal Steroids
The goal of this observational study is to investigate the impact of antenatal corticosteroids (ANS) administration on haematological parameters in premature infants born to women exposed to ANS.
- Trial name
- NCT07358845
- Testing
- Antenatal Corticosteroid Exposure, Antenatal corticosteroids
- Where
- 2 sites in Poland
- Volunteers
- 1,048 people
- Sponsor
- Princess Anna Mazowiecka Hospital, Warsaw, Poland
Polycythemia Vera, Essential Thrombocythemia
A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia
The aim of the present study is to evaluate the efficacy and safety of MK-0683 in the treatment of PV and ET. This agent has most recently been shown to be a potent inhibitor of the autonomous proliferation of haematopoietic…
- Trial name
- NCT00866762
- Testing
- HDAC inhibitor (MK-0683)
- Where
- 16 sites in Denmark, Netherlands and 2 more
- Volunteers
- 60 people
- Sponsor
- Copenhagen University Hospital at Herlev
Hematologic Neoplasms
Take5Care+: A Self-management Educational Intervention
Patients who are diagnosed with haematological malignancies may feel that they have little or no control over their health which can be distressing.
- Trial name
- Take5Care+ (NCT07674212)
- Testing
- Take5Care+
- Volunteers
- 20 people
- Sponsor
- Jitka Vseteckova
Myeloma, Leukemia
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
This study is being conducted to find out how safe and effective different strategies of infection prevention are in comparison to each other, for preventing infection in patients with blood cancers.
- Conditions
- Myeloma, Leukemia, Non Hodgkin's Lymphoma
- Trial name
- NCT07202091
- Testing
- Trimethoprim Sulfamethoxazole, Amoxycillin/clavulanic acid, Immune Globulin Intravenous
- Where
- 3 sites in Australia
- Volunteers
- 900 people
- Sponsor
- Monash University
Acute Myeloid Leukaemia, High Risk Myelodysplastic Syndrome
A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome.
The AML18 Pilot Trial will evaluate the feasibility of three interventions that are planned to be included in the forthcoming NCRI AML18 Trial.
- Trial name
- AML18 Pilot (NCT01236144)
- Testing
- Plerixafor, AC220, Ganetespib
- Where
- 13 sites in United Kingdom
- Volunteers
- 113 people
- Sponsor
- Cardiff University
Myelodysplastic Syndromes, Leukemia Myeloid Acute
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
This is a post-authorization, retrospective multicentre observational nationwide study (PAS-OD). It will be conducted by reviewing medical records and database of patients who participated in the validation of the psychometric…
- Conditions
- Myelodysplastic Syndromes, Leukemia Myeloid Acute, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell
- Trial name
- NCT02842229
- Where
- 15 sites in Spain
- Volunteers
- 117 people
- Sponsor
- Celgene
Myeloma, Non Hodgkin's Lymphoma
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
This study is being conducted to find out how safe and effective different strategies of infection prevention are in comparison to each other, for preventing infection in patients with blood cancers.
- Conditions
- Myeloma, Non Hodgkin's Lymphoma, Leukemia
- Trial name
- NCT07202065
- Testing
- Immune Globulin Intravenous
- Where
- 3 sites in Australia
- Volunteers
- 900 people
- Sponsor
- Monash University
Healthy Participants
Supervision of Clinicians in Oncology by Psycho-oncologists : Evaluation
Communication in the oncology setting involves cognitive as well as emotional challenges for both clinicians and patients, and interactional dimensions that emerge in their encounter.
- Trial name
- SCOPE (NCT07268378)
- Testing
- Supervision session
- Where
- Switzerland
- Volunteers
- 62 people, healthy volunteers welcome
- Sponsor
- Centre Hospitalier Universitaire Vaudois
Medical Oncology, Hematology
Onco-haematology Vigilance Card
The objective of this study is to show the interest of setting up a drug vigilance card in Oncology in order to reinforce patient safety, develop compliance and avoid drug interactions when the patient consults town professionals…
- Conditions
- Medical Oncology, Hematology, Molecular Targeted Therapies
- Trial name
- THERANOVA-LIM (NCT04931329)
- Where
- France
- Volunteers
- 100 people
- Sponsor
- University Hospital, Limoges
Lymphoma, Cancer
Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage
The MiniMax® study is a multicenter randomized controlled study aimed at demonstrating that a combination of non-invasive diagnostic tools are as effective as fiberoptic bronchoscopy and bronchoalveolar lavage (FO-BAL) in…
- Conditions
- Lymphoma, Cancer, Acute Respiratory Failure, Leukemia
- Trial name
- NCT00248443
- Testing
- Fiberoptic bronchoscopy and bronchoalveolar lavage
- Where
- France
- Volunteers
- 206 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Virtual Reality Pain Distraction, Endocrinology
The Influence of Virtual Reality on Blood Parameters
The goal of this study is to learn what the impact of exposure to virtual reality content is on the levels of stress-related blood values in healthy volunteers.
- Conditions
- Virtual Reality Pain Distraction, Endocrinology, Haematology
- Trial name
- 8baan (NCT07042178)
- Testing
- Meditation video at the beach, Rollercoaster video
- Where
- Netherlands
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Van Creveldkliniek
Blood Transfusion, Haematology
Study on Patient Blood Management in Haematological Patients
The investigators noticed a variable prescription of blood components to haematological patients in the hospital. This study will analyze the prescription and administration of blood components to Haematological patients (pre…
- Trial name
- NCT03217370
- Testing
- education of guidelines
- Where
- Belgium
- Volunteers
- 700 people
- Sponsor
- Universitaire Ziekenhuizen KU Leuven